Emerging landscape of COVID-19 vaccines in India, 14 Aug: Bharat Bio, Zydus move to Phase 2; Biological E, Bayor College tie up for COVID-19 vaccine
Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.
Health organizations including the CDC recommend routine immunization for HIV-positive people, who have been unilaterally left out of vaccine trials so far.
Millions of doses will be supplied by both firms, while the vaccines are still in development and negotiations continue with other suppliers.
The US President claimed that the nation has tested 60 million for coronavirus and added that no other country came close to that figure (edited)
For any coronavirus vaccines introduced in India, eVIN will allow data-based decision-making and planning so optimum stocks are maintained, the ministry said.
The agreement will help UK address a key challenge in supply that vaccine makers are likely to face — shortage of vials to rapidly 'fill and finish' tens of thousands of vaccine doses.
ICMR's COVID-19 vaccine symposium saw experts discuss challenge trials, vaccine distribution, preparedness
Many experts outlined that big investments in trials and vaccine development need to be accompanied by big investments in science.
The symposium on 'Novel Ideas in Science and Ethics of Vaccines Against Covid-19' will have leading medical experts and scientists as speakers.
Moderna, Pfizer kick off late-stage COVID-19 vaccine trials; distribution in US by end-2020 a 'stretch goal'
Moderna said it could deliver some 500 million doses a year, and possibly up to 1 billion doses per year, starting in 2021.
The agreement is part of US President Donald Trump's Operation Warp Speed vaccine programme, under which multiple COVID-19 vaccines are being developed
Zydus is only the second Indian pharma firm to get DCGI's nod for human trials of its vaccine candidate.
While the ICMR has said it is important to expedite the clinical trials for a promising indigenous vaccine in the public interest and that all other vaccine candidates across the globe have been similarly fast-tracked, scientists in one voice have cautioned against being over-optimistic
Medical team in Bangladesh suggests combination of Ivermectin and Doxycycline for COVID-19 treatment
As per media reports, the team tested a combination of the antiparasitic drug Ivermectin and the antibiotic Doxycycline on a group of 60 COVID-19 patients.
COVID-19 Vaccine: Here's what you need to know about the second vaccine candidate to start human trials
Headed by the pharmaceutical company Inovio, the trial began on Monday and will include 40 healthy adult volunteers.
Serum Institute of India to develop a COVID-19 vaccine with Codagenix Inc: What are live attenuated vaccines?
Live attenuated vaccines are a type of vaccine which is made from a weakened version of the original microorganism.
WHO’s SOLIDARITY trial is a massive study that will look at four pre-existing drugs that have shown some action against the SARS-CoV-2 virus.